Opportunity Basket
HomeProblemsIdea LabBlogPricingSign inGet started
← Back to Problems

Supplement and bioactive manufacturers struggle to get their active ingredients absorbed by the human body

Supplement companies invest heavily in bioactive compounds, but 60-80% of these ingredients pass through the digestive system without being absorbed, making products ineffective and wasting R&D investment. Current delivery methods (pills, powders, liquids) fail to protect bioactives from stomach acid and liver metabolism, forcing manufacturers to either reformulate at high cost or accept poor efficacy claims that limit market appeal. This directly impacts product efficacy, customer satisfaction, repeat purchases, and regulatory compliance.

Validation Scores

search volume 10%
pain intensity 39%
payment evidence 13%
competition gap 80%

Overall Score: 33.0%

Payment Evidence (1)

Payment Type Saas

Payment intent for saas: app

From: BioClé tackles bioactives’ bioavailability challenge with novel delivery tech

70% confidence Source

Source Signals (1)

BioClé tackles bioactives’ bioavailability challenge with novel delivery tech

The tech utilizes tiny bacterial extracellular vesicles, which have a natural affinity for intestinal cells and can be loaded with bioactives. The post BioClé tackles bioactives’ bioavailability challenge with novel delivery tech appeared first on AgFunderNews ....

Generated Solutions

No solutions generated yet

Generate a solution (sign in)

Sign in and use 1 credit to generate a buildable solution.

Generating solutions… this can take 20-40 seconds. Please wait.

Problem Details

Category
healthcare
Pain Keywords
bioavailability, nutrient absorption, supplement efficacy, delivery mechanism, intestinal permeability, active ingredient loss
Signals Collected
1
Created
2026-10-28 00:20